Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)
53.85
+10.24 (23.48%)
NASDAQ · Last Trade: Apr 29th, 3:03 AM EDT
Detailed Quote
Previous Close
43.61
Open
47.20
Bid
54.00
Ask
54.33
Day's Range
45.01 - 54.23
52 Week Range
21.25 - 54.23
Volume
3,030,905
Market Cap
3.86B
PE Ratio (TTM)
71.80
EPS (TTM)
0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
801,390
Chart
About Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)
Kiniksa Pharmaceuticals International Plc is a biotechnology company focused on developing innovative therapies for autoimmune and rare diseases. The company is engaged in advancing its pipeline of novel product candidates that target critical unmet medical needs, leveraging its expertise in immunology and inflammation. Kiniksa aims to bring effective treatments to patients through rigorous research and developmental strategies, seeking to improve the quality of life for individuals affected by challenging health conditions. Read More
Kiniksa Pharmaceuticals (KNSA) exemplifies a high-growth momentum stock with strong fundamentals and a positive technical setup for potential breakout.
4 analysts have expressed a variety of opinions on Kiniksa Pharmaceuticals (NASDAQ: KNSA) over the past quarter, offering a diverse set of opinions from bullish to bearish.
